via Kagan Institute
Breakthrough by experts supports drug therapy as alternative to surgery
World-leading eye experts have made a breakthrough that could potentially change the way cataracts are treated – with potential for drug therapy to replace surgery.
Cataract is a clouding of the eye lens that develops over time and affects the quality of vision. It is caused by an accumulation of protein in the lens that reduce the transmission of light to the retina. Previous research led by ARU found that cataracts account for almost half of global cases of blindness.
A significantly developed cataract can only currently be treated by a surgical procedure to remove the cloudy lens and insert an artificial replacement.
A team of international scientists, led by Professor Barbara Pierscionek of Anglia Ruskin University (ARU), has published peer-reviewed research that shows the sophisticated optics of the lens develops much earlier in gestation than has previously been thought possible. They also found how a particular protein (aquaporin) responsible for water passage in the lens disrupts the optical development, leading to cataract formation.
The scientists have spent more than a decade conducting the most precise measurements on optics of the lens at SPring-8, the world’s largest and most powerful synchrotron, in Japan.
The synchrotron is a particle accelerator that produces powerful X-rays by accelerating electrons to the speed of light. The X-rays allow measurements to be taken with the highest accuracy yet on optical properties of the eye.
The project team is the first in the world to have measured how the optics in the eye lens develop. Their research was presented earlier this month at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting.
Professor Pierscionek, Deputy Dean (Research and Innovation) for the Faculty of Health, Education, Medicine and Social Care and member of the Medical Technology Research Centre at ARU, said: “Cataracts are one of the main causes of vision loss and blindness worldwide, yet for many people surgery is inaccessible for various reasons.
“Our findings indicate the role of the aquaporin proteins and the crucial importance of this for the lens to work correctly and the eye to see clearly.
“Further research in this area is planned, but this discovery, together with our research on nanotechnologies that indicate drug therapy for cataract is possible, could potentially revolutionise the way cataract is treated, opening up the field for drug-based therapy rather than surgery. This would have exciting implications for public health.”
Original Article: New research may revolutionise cataract treatment
More from: Anglia Ruskin University
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Cataracts
- Harvard Health Publishing And 3 More Doctors Weigh In On: When Should You Get Your Cataracts Removed?
Answered by Dr. Howard E. Lewine M.D. Chief Medical Editor, Harvard Health Publishing · 40 years of experience · USA Typically, the vision changes associated with cataracts slowly worsen over time.
- GlassesUSA.com Can Help Protect Your Eyes From the Sun and the Screen
For those who wear glasses while driving, prescription sunglasses are a must-have. Not only do they protect your eyes, but they allow you to drive safely. Compromising your sight when driving in the ...
- The Evolution of Cataract Surgery: The Most Common Eye Procedure in Older Adults
[12] In ancient times, cataracts were treated with a technique called couching, which could only be performed when the lens had become completely opaque, rigid, and heavy to the point that the ...
- Are you one of the millions about to have cataract surgery? Here’s what ophthalmologists say you need to know
As ophthalmologists who have performed thousands of these procedures, we know that many patients have misconceptions about both cataracts and the surgery. For example, some think a cataract is a ...
- Cloudy, with a chance for clear vision
Cataracts are a normal part of aging. But the surgery to remove them is remarkably safe, with brief recovery times and few complications.
Go deeper with Google Headlines on:
Cataracts
[google_news title=”” keyword=”cataracts” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Drug therapy for cataracts
- Aurion Biotech doses first Canadian patient in Phase 1/2 ABA-1, CLARA clinical trial of AURN001
The 1-time, intracameral injection is a cell therapy for the treatment of corneal edema secondary to corneal endothelial dysfunction.
- Preparing for an allergic reaction
Allergic reactions can range from irritating sneezing fits to life-threatening episodes. An allergy specialist with Baylor College of Medicine gives ...
- Navigating ocular effects of cancer therapy: Insights from breast cancer and head-neck cancers
The symptoms related to targeted cancer therapy (TCT) and immunotherapy for head and neck cancers include photosensitivity, loss of eyelashes, uveitis, changes in color perception, conjunctivitis, ...
- Borealis Achieves FDA Approval for Borcycle™ M Post-Consumer Recycled Plastics in Food-Grade Packaging
Borealis has received Letters of No Objection (LNOs) from the US Food & Drug Administration (FDA) for specific grades of its Borcycle™ M post ...
- Three new McNair Scholars join Baylor College of Medicine as the College hosts the 12th annual McNair Symposium
The McNair Scholars program at Baylor College of Medicine has announced three new scholars focusing on how cell and neural activity affect behavior ...
Go deeper with Google Headlines on:
Drug therapy for cataracts
[google_news title=”” keyword=”drug therapy for cataracts” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]